A Thomas-Joulié, S Tran, L El Houari, A Seyve, F Bielle, C Birzu, F Lozano-Sanchez, K Mokhtari, M Giry, Y Marie, F Laigle-Donadey, C Dehais, C Houillier, D Psimaras, A Alentorn, A Laurenge, M Touat, M Sanson, K Hoang-Xuan, A Kas, L Rozenblum, M-O Habert, L Nichelli, D Leclercq, D Galanaud, J Jacob, C Karachi, L Capelle, A Carpentier, B Mathon, L Belin, A Idbaih
BACKGROUND: Glioblastoma (GBM) is the most common devastating primary brain cancer in adults. In our clinical practice, median overall survival (mOS) of GBM patients seems increasing over time. METHODS: To address this observation, we have retrospectively analyzed the prognosis of 722 newly diagnosed GBM patients, aged below 70, in good clinical conditions (i.e. Karnofsky Performance Status -KPS- above 70%) and treated in our department according to the standard of care (SOC) between 2005 and 2018...
March 11, 2024: European Journal of Cancer